![]() Angionetics Angionetics is a company focused on the late-stage clinical development and commercialization of Generx, an angiogenic gene therapy product candidate designed for medical revascularization for the potential treatment of patients with myocardial ischemia and refractory angina due to advanced coronary artery disease. | |||
Founding Date | Founding Date N/A | Founding Date 2018 | Founding Date 1998 |
Type | Type Subsidiary | Type Private | Type Private |
Tags | |||
Locations | Locations San Diego, US HQ | Locations Seattle, US HQ | Locations Évry-Courcouronnes, FR HQ |
Employees | Employees N/A | Employees 47 | Employees 981% increase |
Variant Bio is a biotechnology company that develops human genetic diversity therapies.
View companyGenopole is a research center that focuses on the development of biotechnology industries.
View company